Overview

Study Assessing SEP-363856 in Male and Female Volunteers With High or Low Schizotype Characteristics

Status:
Completed
Trial end date:
2015-07-01
Target enrollment:
Participant gender:
Summary
This study is designed to evaluate the effects of a single dose of SEP-363856 in healthy male and female volunteers with high or low schizotype characteristics.
Phase:
Phase 1
Details
Lead Sponsor:
Sunovion
Treatments:
Amisulpride
Sulpiride
Sultopride